End Taxpayer Subsidies for Drug Ads Act
Official title: To amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for prescription drugs.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the House Committee on Ways and Means.
End Taxpayer Subsidies for Drug Ads Act
This bill prohibits tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs.
Direct-to-consumer advertising is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is (1) in regard to the drug product, and (2) primarily targeted to the general public.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 8399: End Taxpayer Subsidies for Drug Ads Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-8399/
"H.R. 8399: End Taxpayer Subsidies for Drug Ads Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-8399/.
H.R. 8399, 116th Cong. (2026), https://openamerica.io/bill/116-HR-8399/.
[H.R. 8399: End Taxpayer Subsidies for Drug Ads Act](https://openamerica.io/bill/116-HR-8399/)